Clinical Trial Update: Clinical Trial on Binge Eating Disorder, Treatment With Naloxone Spray [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows a Phase 2/Phase 3 study evaluating Naloxone spray for Binge Eating Disorder, sponsored by Lightlake Sinclair Ltd; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Naloxone spray (naloxone)

Snippet

Sponsor: Lightlake Sinclair Ltd. | Conditions: Binge Eating Disorder | Phase 2, Phase 3 | Status: UNKNOWN